Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2022 | Story Leonie Bolleurs and Rulanzen Martin

After two years of lockdown, online meetings, and limited contact with colleagues, academy at the University of the Free State (UFS) is gradually returning to normal. This month (February 2022), staff, students, and members of related industries will convene on three different occasions to learn about cutting-edge scholarship, to reconnect with each other, and to discuss issues impacting society in the fields of theology, the humanities, and agriculture.

Seminar on ‘The Limits of Decolonisation’ with Prof RW Johnson 

Date: 24 February 2022
Time: 09:00-16:00 SAST
Venue/Platform: Equitas Auditorium, UFS Bloemfontein Campus, and Microsoft Teams 
Microsoft Teams link: https://bit.ly/3Llejew 

Decolonisation has been a heated point of discussion for some time now, but have you ever wondered if there could be limitations hindering the decolonisation project?  The Departments of Political Studies and Governance and Philosophy and Classics at the UFS will host an array of academics and experts for a hybrid seminar on the topic The Limits of Decolonisation.

If decolonisation is an important issue for you or if you are interested in the topic and its relevance and influence in the world and academia, you should join or attend the seminar – either online via Microsoft Teams or in person in the Equitas Auditorium – on 24 February 2022 from 09:00. 

The keynote speaker is political scientist Prof RW Johnson from the University of Oxford. Prof Johnson is an emeritus fellow at Magdalen College and is the author of several acclaimed political books.  The other speakers are all from the Departments of Political Studies and Governance, and Philosophy and Classics. Terrence Corrigan from the South African Institute of Race Relations will speak on The relationship between critical race theory and decolonisation. 

Find full programme here

RSVP: Alice Stander StanderAFM@ufs.ac.za  (please specify dietary requirements, as a light lunch will be served) 


 

 

 

 

 

 

 

 

 

 

 

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept